Thirty-day outcomes and biomarker results for patients in the derivation and validation cohorts
| Outcome | Derivation sample (n = 151) | Validation sample (n = 106) | p Value |
| NSTEMI | 5 (3) | 14 (13) | <0.01* |
| IMA positive | 4 (80) | 10 (71) | 1.0* |
| Initial hsTnT positive | 0 (0) | 6 (43) | 0.13* |
| Both markers negative | 1 (20) | 2 (14) | 1.0* |
| Revascularisation | 6 (4) | 12 (11) | 0.02† |
| IMA positive | 3 (50) | 11 (92) | 0.08* |
| Initial hsTnT positive | 0 (0) | 3 (25) | 0.52* |
| Both markers negative | 3 (50) | 1 (8) | 0.08* |
| Death | 0 (0) | 2 (2) | 0.17* |
| IMA positive | 0 | 2 (100) | N/A |
| Initial hsTnT positive | 0 | 2 (100) | N/A |
| Both markers negative | 0 | 0 (0) | N/A |
| Any MACE‡ | 8 (5.3) | 21 (19.8) | <0.001† |
hsTnT, highly sensitive cardiac troponin T; IMA, ischaemia-modified albumin; MACE, major adverse cardiac event; NSTEMI, non-ST elevation myocardial infarction.
Values are presented as n (% in outcome category).
Significant p values are in bold font.
*Fisher exact test for categorical variables.
† χ2 Test for categorical variables.
‡Some patients had more than one adverse outcome.